Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia
NCT02511509, Not applicable, Unknown, Medical University of Lodz
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia | ClinicalTrials.gov |
| NCT number | NCT02511509 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 100 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Medical University of Lodz | ClinicalTrials.gov |
| Conditions | Schizophrenia | ClinicalTrials.gov |
| Interventions | Bifrontal electroconvulsive therapy, Bitemporal electroconvulsive therapy | ClinicalTrials.gov |
| First posted | 2015-07-30 | ClinicalTrials.gov |
| Last updated | 2016-10-03 | ClinicalTrials.gov |
Registered outcomes 15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Positive and Negative Syndrome Scale | up to 5 weeks | Assessment conducted on baseline, after 6th, 12th and the last ECT. | ClinicalTrials.gov |
| Primary | Clinical Global Impression | up to 5 weeks | Assessment conducted on baseline, after 6th, 12th and the last ECT. | ClinicalTrials.gov |
| Primary | Memorial Delirium Assessment Scale | up to 5 weeks | Assessment conducted after the each ECT course. | ClinicalTrials.gov |
| Primary | Confusion Assessment Method | up to 5 weeks | Assessment conducted after the each ECT course. | ClinicalTrials.gov |
| Primary | Verbal Memory Test | up to 5 weeks | Assessment conducted on baseline, after the 6th ECT and one week after the last ECT (24 hours after each ECT course). | ClinicalTrials.gov |
| Primary | Visual Memory Test | up to 5 weeks | Assessment conducted on baseline, after the 6th ECT and one week after the last ECT (24 hours after each ECT course). | ClinicalTrials.gov |
| Primary | Finger Tapping Test | up to 5 weeks | Assessment conducted on baseline, after the 6th ECT and one week after the last ECT (24 hours after each ECT course) | ClinicalTrials.gov |
| Primary | Symbol Digit Coding Test | up to 5 weeks | Assessment conducted on baseline, after the 6th ECT and one week after the last ECT (24 hours after each ECT course) | ClinicalTrials.gov |
| Primary | Stroop Test | up to 5 weeks | Assessment conducted on baseline, after the 6th ECT and one week after the last ECT (24 hours after each ECT course) | ClinicalTrials.gov |
| Primary | Shifting Attention Test | up to 5 weeks | Assessment conducted on baseline, after the 6th ECT and one week after the last ECT (24 hours after each ECT course) | ClinicalTrials.gov |
| Primary | Continuous Performance Test | up to 5 weeks | Assessment conducted on baseline, after the 6th ECT and one week after the last ECT (24 hours after each ECT course). | ClinicalTrials.gov |
| Secondary | Positron Emission Tomography to assess the impact of ECT on the dopaminergic system activity | up to 5 weeks | Assessment conducted before the first and after the last ECT course. | ClinicalTrials.gov |
| Secondary | The concentration of brain-derived neurotrophic factor. | up to 5 weeks | The blood samples will be collected on baseline, 2 and 6 hours after the first ECT course, 2 hours after the 3rd, 6th, 9th and the last ECT course | ClinicalTrials.gov |
| Secondary | The concentration of neuron specific enolase. | up to 5 weeks | The blood samples will be collected on baseline, 2 and 6 hours after the first ECT course, 2 hours after the 3rd, 6th, 9th and the last ECT course | ClinicalTrials.gov |
| Secondary | The concentration of protein S100B | up to 5 weeks | The blood samples will be collected on baseline, 2 and 6 hours after the first ECT course, 2 hours after the 3rd, 6th, 9th and the last ECT course | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Continuous Performance Test | Primary outcome | ConductCognition |
| Finger Tapping Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)